Parkinson's disease(PD)is the second most common neurodegenerative disease,affecting around 1.0%of the population over 65 years of age[1].In China,there are estimated to be more than 3 million PD patients,with eac...Parkinson's disease(PD)is the second most common neurodegenerative disease,affecting around 1.0%of the population over 65 years of age[1].In China,there are estimated to be more than 3 million PD patients,with each year about 100,000 PD patients being newly diagnosed.Along with China stepping into an aging society,it was estimated that in 2030,there would be around 5 million PD patients in China alone,which would create huge socioeconomic burdens on patients and their families.展开更多
基金supported by the Beijing Municipal Science&Technology Commission(Z221100007422016 and Z221100002722007)the National Natural Science Foundation of China(82171250 and 82030037)+3 种基金the STI2030-Major Projects(2021ZD0201801)the Translational and Application Project of Brain-inspired and Network Neuroscience on Brain Disorders,Beijing Municipal Health Commission(11000023T000002036286)the Beijing Talents Foundation(2017000021223TD03)the Beijing Municipal Health Commission Fund(PXM2020_026283_000005)。
文摘Parkinson's disease(PD)is the second most common neurodegenerative disease,affecting around 1.0%of the population over 65 years of age[1].In China,there are estimated to be more than 3 million PD patients,with each year about 100,000 PD patients being newly diagnosed.Along with China stepping into an aging society,it was estimated that in 2030,there would be around 5 million PD patients in China alone,which would create huge socioeconomic burdens on patients and their families.
